# MASSACHUSETTS BIOTECHNOLOGY COUNCIL hires NOVEL STRATEGIES (FKA) PRISM GROUP (Health Issues)

**Score:** 45/100

| Field | Value |
|---|---|
| Client | MASSACHUSETTS BIOTECHNOLOGY COUNCIL |
| Client description | MassBio is a trade association championing the next generation of cures and therapies. |
| Client state | MA |
| Lobbying firm | NOVEL STRATEGIES (FKA) PRISM GROUP |
| Firm state | DC |
| Issue areas | Health Issues |
| Specific matters disclosed | Modernizing clinical trials and the regulatory process at the Food and Drug Administration |
| Registered | 2026-10-20 |

## Why this score
- Specific matters disclosed.

Source: U.S. Senate and House Lobbying Disclosure Act (LDA) filings via lda.gov; Colorado Secretary of State, NYC City Clerk eLobbyist and City of Chicago Board of Ethics lobbying data (https://lda.gov/filings/public/filing/1ccbfacb-92b2-4744-adfb-5c2bea9b7221/print/). Last refreshed: 2026-11-03T19:42:41.566Z.
From public Lobbying Disclosure Act registrations (lda.gov) and Colorado, New York City and City of Chicago lobbying disclosures. Organization level only: we never list lobbyist, CEO or contact names, and clients whose name reads as a person are left out. Chicago amounts are lobbyist compensation reported for the quarter, summed by client. A registration reports intent to lobby; it is not evidence of wrongdoing.